CytoChip Inc. develops advanced microfluidic point-of-care diagnostic solutions, highlighted by their flagship CitoCBC® analyzer—the first cartridge-based Complete Blood Count (CBC) system to achieve a CLIA Waiver. Utilizing miniaturized fluorescent flow cytometry integrated into single-use chips, CytoChip replaces complex lab instrumentation with rapid, lab-quality 5-part differential blood tests that yield results in just eight minutes.